Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 16 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Asc)]
Φίλτρα: Συντάκτης is Ortiz, Alberto  [Clear All Filters]
2020
Sarafidis, P., Loutradis C., Ortiz A., & Ruilope L. M. (2020).  Blood pressure targets in patients with chronic kidney disease: MDRD and AASK now confirming SPRINT.. Clin Kidney J. 13(3), 287-290.
Sarafidis, P., Ferro C. J., Morales E., Ortiz A., Malyszko J., Hojs R., et al. (2020).  Erratum.. Nephrol Dial Transplant. 35(8), 1452.
Fernandez-Fernandez, B., D'Marco L., Gorriz J. Luis, Jacobs-Cachá C., Kanbay M., Luis-Lima S., et al. (2020).  Exploring Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors for Organ Protection in COVID-19.. J Clin Med. 9(7), 
Ferro, C. J., Sarafidis P., & Ortiz A. (2020).  Lipoprotein(a) Reduction in Persons with Cardiovascular Disease.. N Engl J Med. 382(21), e65.
Potpara, T. S., Ferro C., Lip G. Y. H., Dan G. A., Lenarczyk R., Mallamaci F., et al. (2020).  Management of atrial fibrillation in patients with chronic kidney disease in clinical practice: a joint European Heart Rhythm Association (EHRA) and European Renal Association/European Dialysis and Transplantation Association (ERA/EDTA) physician-based su. Europace. 22(3), 496-505.
Sarafidis, P. A., & Ortiz A. (2020).  The risk for urinary tract infections with sodium-glucose cotransporter 2 inhibitors: no longer a cause of concern?. Clin Kidney J. 13(1), 24-26.
Sarafidis, P., Ferro C. J., Morales E., Ortiz A., Malyszko J., Hojs R., et al. (2020).  SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA.. Nephrol Dial Transplant. 35(10), 1825.
Fernandez-Fernandez, B., Sarafidis P., Kanbay M., Navarro-González J. F., Soler M. José, Gorriz J. Luis, et al. (2020).  SGLT2 inhibitors for non-diabetic kidney disease: drugs to treat CKD that also improve glycaemia.. Clin Kidney J. 13(5), 728-733.
Sarafidis, P., Loutradis C., Ferro C. J., & Ortiz A. (2020).  SGLT-2 Inhibitors to Treat Hyponatremia Associated with SIADH: A Novel Indication?. Am J Nephrol. 51(7), 553-555.
2019
Ferro, C. J., Mark P. B., Kanbay M., Sarafidis P., Heine G. H., Rossignol P., et al. (2019).  Author Correction: Lipid management in patients with chronic kidney disease.. Nat Rev Nephrol. 15(2), 121.
Sarafidis, P., Ferro C. J., Morales E., Ortiz A., Malyszko J., Hojs R., et al. (2019).  SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA.. Nephrol Dial Transplant. 34(2), 208-230.
2018
Ferro, C. J., Mark P. B., Kanbay M., Sarafidis P., Heine G. H., Rossignol P., et al. (2018).  Lipid management in patients with chronic kidney disease.. Nat Rev Nephrol. 14(12), 727-749.
2017
Sarafidis, P. A., Persu A., Agarwal, iv R., Burnier M., de Leeuw P., Ferro C., et al. (2017).  Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kid. J Hypertens. 35(4), 657-676.
Sarafidis, P. A., Persu A., Agarwal, iv R., Burnier M., de Leeuw P., Ferro C. J., et al. (2017).  Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidne. Nephrol Dial Transplant. 32(4), 620-640.
Zoccali, C., Vanholder R., Massy Z. A., Ortiz A., Sarafidis P., Dekker F. W., et al. (2017).  The systemic nature of CKD.. Nat Rev Nephrol. 13(6), 344-358.
2015
Murray, C. J. L., Barber R. M., Foreman K. J., Ozgoren A. Abbasoglu, Abd-Allah F., Abera S. F., et al. (2015).  Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition.. Lancet. 386(10009), 2145-91.

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές